Supplementary Figure Legends 1-3 from Antitumor Activity of the Hsp90 Inhibitor IPI-504 in HER2-Positive Trastuzumab-Resistant Breast Cancer

MLA

José Baselga, et al. Supplementary Figure Legends 1-3 from Antitumor Activity of the Hsp90 Inhibitor IPI-504 in HER2-Positive Trastuzumab-Resistant Breast Cancer. Apr. 2023. EBSCOhost, https://doi.org/10.1158/1535-7163.22497187.v1.

APA

José Baselga, Claudia Aura, José Jimenez, Ludmila Prudkin, Varenka Rodriguez, Kip A. West, Kelly L. Slocum, Alice R. Lim, Olga Rodriguez, Marta Guzman, Emmanuel Normant, Violeta Serra, & Maurizio Scaltriti. (2023). Supplementary Figure Legends 1-3 from Antitumor Activity of the Hsp90 Inhibitor IPI-504 in HER2-Positive Trastuzumab-Resistant Breast Cancer. https://doi.org/10.1158/1535-7163.22497187.v1

Chicago

José Baselga, Claudia Aura, José Jimenez, Ludmila Prudkin, Varenka Rodriguez, Kip A. West, Kelly L. Slocum, et al. 2023. “Supplementary Figure Legends 1-3 from Antitumor Activity of the Hsp90 Inhibitor IPI-504 in HER2-Positive Trastuzumab-Resistant Breast Cancer,” April. doi:10.1158/1535-7163.22497187.v1.